Pharmaceutical Supply Chain Management
The presentation will cover how to establish good supply chain procedures and what to seek in such a system. This webinar will include the FDA’s recent guidance document on supply chain for Compounding Pharmacies and how others can use these same standards.
March 19, 2020
10:00 AM PST | 01:00 PM EST
More Trainings by this Expert
Product Id : 502882
Live: One Dial-in One Attendee
Corporate Live: Any number of participants
Recorded: Access recorded version, only for one participant unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
Corporate Recorded: Access recorded version, Any number of participants unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
The presentation will include recent comments by MCA and FDA on the use of criminal supply chains and how to spot them.
The presentation will review the current situation of recent recalls by small firms. The presentation will cover how to establish good supply chain procedures and what to seek in such a system.
The presentation will include FDAs recent guidance document on supply chain for Compounding Pharmacies and how others can use these same standards.
Why should you Attend:
Why attend? The major reason for small pharmaceutical companies to enter into a recall situation is the poor quality of raw materials and active ingredients.
Currently, we face issues with generic drug supplies where carcinogens appear in our blood pressure medications, affecting millions of us.
Compounding pharmacies, generic firms, and small pharmaceutical companies struggle with adequate and compliant supply chain. In addition, many firms suffer from the criminal suppliers. Both MCA and FDA warn firms about the potential use.
Areas Covered in the Session:
Who Will Benefit:
- Criminals in Supply Chain Management
- FDA and MCA comments on criminal activities
- Recent Recalls due to lack of supply chain management
- Proper testing requirements
- How to avoid a recall due to supply chain
- Regulatory Affairs
- Supply Chain
Courtland Imel is CEO of Ceutical Laboratories. Courtland has provided training to FDA, Health Canada, and state regulatory authorities. Courtland has spoken at AFDO, AFDOSS, MCAFDO, ASQ, SCC, and Bio. Courtland has 35 years of experience in the industry. Courtland is an SME for several organizations and law firms. Courtland worked for M&M Mars, Allergan, ILEX Oncology, Aronex Pharmaceuticals, Mills Biopharmaceuticals, International Isotopes, Avail Medical Products, Carrington Laboratories, and Ceutical Laboratories, Inc. Courtland has assisted in the submissions of 510Ks, PMAs, IND’s, NDAs, ANDAs, IDEs, and more.
Ceutical Labs provides many services including product development, formulation development, analytical testing (chemistry, microbiology, and physical), regulatory submissions, electronic submissions, consulting, training, quality systems, and more.